1. Structure, Activity, and Function of the Protein Lysine Methyltransferase G9a
    Coralie Poulard et al, 2021, Life CrossRef
  2. Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells
    Yue-peng Cao et al, 2019, Acta Pharmacologica Sinica CrossRef
  3. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer
    Christian Mayr et al, 2018, Human Pathology CrossRef
  4. G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner
    Lei Hu et al, 2018, Cell Death & Disease CrossRef
  5. Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities
    Matteo Canale et al, 2020, International Journal of Molecular Sciences CrossRef
  6. Discovery of Novel Substrate-Competitive Lysine Methyltransferase G9a Inhibitors as Anticancer Agents
    Yosuke Nishigaya et al, 2023, Journal of Medicinal Chemistry CrossRef
  7. Insights for the design of protein lysine methyltransferase G9a inhibitors
    Mariasoosai Ramya Chandar Charles et al, 2019, Future Medicinal Chemistry CrossRef
  8. Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities
    Katia De Marco et al, 2023, Cancers CrossRef
  9. Targeting H3K9 methyltransferase G9a and its related molecule GLP as a potential therapeutic strategy for cancer
    Ziaur Rahman et al, 2021, Journal of Biochemical and Molecular Toxicology CrossRef
  10. Molecular and functional anticancer effects of GLP/G9a inhibition by UNC0646 in MeWo melanoma cells
    Luma Dayane de Carvalho Filiú-Braga et al, 2024, Heliyon CrossRef
  11. Targeting EHMT2/ G9a for cancer therapy: Progress and perspective
    Suraya Jan et al, 2021, European Journal of Pharmacology CrossRef
  12. Histone modification dynamics as revealed by a multicolor immunofluorescence-based single-cell analysis
    Yoko Hayashi-Takanaka et al, 2020, Journal of Cell Science CrossRef
  13. EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms
    Alamelu Nachiyappan et al, 2022, The FEBS Journal CrossRef
  14. Insight into the multi-faceted role of the SUV family of H3K9 methyltransferases in carcinogenesis and cancer progression
    Nirmalya Saha et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  15. GLP overexpression is associated with poor prognosis in Chronic Lymphocytic Leukemia and its inhibition induces leukemic cell death
    Juliana Carvalho Alves-Silva et al, 2018, Investigational New Drugs CrossRef
  16. G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating mTOR
    Chao Yin et al, 2019, The FASEB Journal CrossRef
  17. Mechanism of G9a inhibitor BIX-01294 acting on U251 glioma cells
    Ai-Shun Guo et al, 2016, Molecular Medicine Reports CrossRef
  18. Upregulated expression of G9a is correlated with poor prognosis of gastric cancer patients
    Chi Zhang et al, 2019, Medicine CrossRef